Table 2 Comparison of end-of-life decision and their intention between 2022 overseas France and 2010 mainland

Medical end-of-life practice knowing that they possibly or certainly hastened death

 Treatment withheld

450

40.58

[37.41–43.75]

1608

38.95

[37.45–40.46]

knowing that the decision may hasten death

438

39.36

[36.21–42.51]

1539

37.29

[35.80-38.78]

with the intention of hastening death

12

1.22

[0.46–1.98]

69

1.66

[1.27–2.06]

 Treatment withdrawn

182

14.94

[12.76–17.12]

544

12.99

[11.96–14.01]

knowing that the decision may hasten death

169

13.99

[11.86–16.12]

475

11.36

[10.39–12.33]

with the intention of hastening death

13

0.96

[0.40–1.51]

69

1.62

[1.24–2.01]

 Intensification of treatment to alleviate pain and/or symptoms *

444

38.86

[35.73–41.99]

1401

33.73

[32.27–35.18]

knowing that the decision may hasten death*

425

37.36

[34.25–40.46]

1344

32.35

[30.91–33.79]

with the intention of hastening death

19

1.50

[0.78–2.23]

57

1.38

[1.02–1.74]

 Deep and continuous sedation until death

158

13.31

[11.17–15.46]

 Use of drugs to deliberate end life

17

1.32

[0.64–2.01]

36

0.92

[0.62–1.22]

at patient’s request

5

0.35

[0.04–0.67]

10

0.26

[0.10–0.4]

Medical decision without any intention regarding death

Treatment withheld

84

8.09

[6.28–9.90]

329

7.93

[7.10–8.77]

Treatment withdrawn

19

1.33

[0.71–1.94]

89

2.09

[1.66–2.52]

intensification of treatment to alleviate symptoms with medication with opioids or benzodiazepines

114

11.47

[9.30-13.64]

395

9.42

[8.53–10.32]

intensification of treatment to alleviate symptoms with medication other than opioids or benzodiazepines*

22

2.00

[1.11–2.88]

199

4.87

[4.20–5.53]

Life prolonging treatment

398

34.83

[31.78–37.88]

1554

36.96

[35.47–38.44]

None of the investigated decisions

176

17.68

[15.12–20.23]

735

18.75

[17.52–19.97]